WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H123934
CAS#: 150085-21-5
Description: S1R agonist 2 (Compound 8b) is a selective S1R agonist.
Hodoodo Cat#: H123934
Name: S1R agonist 2
CAS#: 150085-21-5
Chemical Formula: C21H27NO
Exact Mass: 309.21
Molecular Weight: 309.450
Elemental Analysis: C, 81.51; H, 8.79; N, 4.53; O, 5.17
Synonym: 150085-21-5; S1R agonist; S1R agonist-2; S1R-agonist-2; Compound 8b
IUPAC/Chemical Name: 4-benzyl-1-(3-phenoxypropyl)piperidine
InChi Key: KOYQYIAABUPJFF-UHFFFAOYSA-N
InChi Code: InChI=1S/C21H27NO/c1-3-8-19(9-4-1)18-20-12-15-22(16-13-20)14-7-17-23-21-10-5-2-6-11-21/h1-6,8-11,20H,7,12-18H2
SMILES Code: C1(OCCCN2CCC(CC2)CC3=CC=CC=C3)=CC=CC=C1
Appearance: To be determined
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 309.45 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: Váczi S, Barna L, Harazin A, Mészáros M, Porkoláb G, Zvara Á, Ónody R,
Földesi I, Veszelka S, Penke B, Fülöp L, Deli MA, Mezei Z. S1R agonist modulates
rat platelet eicosanoid synthesis and aggregation. Platelets. 2022 Jul
4;33(5):709-718. doi: 10.1080/09537104.2021.1981843. Epub 2021 Oct 26. PMID:
34697991.
2: Dalwadi DA, Kim S, Schetz J, Schreihofer DA, Kim S. Brain-derived
neurotrophic factor for high-throughput evaluation of selective Sigma-1 receptor
ligands. J Pharmacol Toxicol Methods. 2022 Jan-Feb;113:107129. doi:
10.1016/j.vascn.2021.107129. Epub 2021 Oct 20. PMID: 34678430; PMCID:
PMC9358981.
3: Mavlyutov TA, Baker EM, Losenegger TM, Kim JR, Torres B, Epstein ML, Ruoho
AE. The Sigma-1 Receptor-A Therapeutic Target for the Treatment of ALS? Adv Exp
Med Biol. 2017;964:255-265. doi: 10.1007/978-3-319-50174-1_17. PMID: 28315276.
4: Zhemkov V, Geva M, Hayden MR, Bezprozvanny I. Sigma-1 Receptor (S1R)
Interaction with Cholesterol: Mechanisms of S1R Activation and Its Role in
Neurodegenerative Diseases. Int J Mol Sci. 2021 Apr 15;22(8):4082. doi:
10.3390/ijms22084082. PMID: 33920913; PMCID: PMC8071319.
5: Dichiara M, Ambrosio FA, Barbaraci C, González-Cano R, Costa G, Parenti C,
Marrazzo A, Pasquinucci L, Cobos EJ, Alcaro S, Amata E. Synthesis, Computational
Insights, and Evaluation of Novel Sigma Receptors Ligands. ACS Chem Neurosci.
2023 May 17;14(10):1845-1858. doi: 10.1021/acschemneuro.3c00074. Epub 2023 May
8. PMID: 37155827; PMCID: PMC10197133.